ADMA Biologics Inc Options
ADMA options chain
Explore expirations, strikes, liquidity, live quotes and Greeks in the context of the same company overview.
Options Chain SnapshotA bounded snapshot of up to 200 active contracts in the displayed expiration and strike window. Close and open interest are reference fields, not live quotes.
Up to 200 active ADMA contracts expiring in the next 7–45 days, with strikes within ±25% of the current price.
| Expiration | Days to expiry | Shown contracts |
|---|---|---|
| 2026-11-20 | 15 | 14 |
| 2026-12-18 | 43 | 14 |
| Type | Strike | Expiry | Open interest | Close |
|---|---|---|---|---|
| Call | $10.00 | 2026-11-20 | 375 | $1.15 |
| Call | $11.00 | 2026-11-20 | 17,571 | $0.64 |
| Call | $12.00 | 2026-11-20 | 536 | $0.45 |
| Call | $13.00 | 2026-11-20 | 2,541 | $0.18 |
| Call | $14.00 | 2026-11-20 | 619 | $0.15 |
| Call | $15.00 | 2026-11-20 | 988 | $0.08 |
| Call | $16.00 | 2026-11-20 | 3,003 | $0.37 |
| Put | $10.00 | 2026-11-20 | 1,490 | $0.60 |
| Put | $11.00 | 2026-11-20 | 51 | $1.27 |
| Put | $12.00 | 2026-11-20 | 39 | $0.85 |
| Put | $13.00 | 2026-11-20 | 7 | $3.52 |
| Put | $14.00 | 2026-11-20 | 8 | $5.78 |
| Put | $15.00 | 2026-11-20 | — | $7.00 |
| Put | $16.00 | 2026-11-20 | — | — |
| Call | $10.00 | 2026-12-18 | 14 | $1.42 |
| Call | $11.00 | 2026-12-18 | 2 | $0.99 |
| Call | $12.00 | 2026-12-18 | 5 | $0.60 |
| Call | $13.00 | 2026-12-18 | — | — |
| Call | $14.00 | 2026-12-18 | — | — |
| Call | $15.00 | 2026-12-18 | 3 | $0.20 |
| Call | $16.00 | 2026-12-18 | — | — |
| Put | $10.00 | 2026-12-18 | 18 | $0.70 |
| Put | $11.00 | 2026-12-18 | 98 | $1.20 |
| Put | $12.00 | 2026-12-18 | 53 | $1.85 |
| Put | $13.00 | 2026-12-18 | — | — |
| Put | $14.00 | 2026-12-18 | — | — |
| Put | $15.00 | 2026-12-18 | — | — |
| Put | $16.00 | 2026-12-18 | — | — |
- Source
- US listed-options contracts feed
- Observed
- Cadence
- Five-minute cached contract snapshot
- Status
- fresh
Live Quotes & GreeksThis analysis is included with a paid membership. Public prices, charts and source-attributed news remain available without a subscription. Membership does not guarantee an investment outcome.
Options Ideas & Decision IntelligenceThis analysis is included with a paid membership. Public prices, charts and source-attributed news remain available without a subscription. Membership does not guarantee an investment outcome.
Asset BackgroundSource-supported background about this asset. The sources and review status are listed with the reference.
ADMA options refer to ADMA BIOLOGICS, INC. as their underlying. ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment.
AI-selected reference, checked against source evidence · Evidence observed
Frequently Asked QuestionsSource-linked answers to common questions about this asset. Check the evidence observation date and whether the reference was reviewed by a person.
- What business does ADMA BIOLOGICS, INC. operate?
- ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment.
- How do ADMA options relate to the underlying company?
- The published options record identifies ADMA as an underlying symbol. Options contracts reference that underlying; expiration, strike and option type define each separate contract.
What to WatchAI-assisted topics for further research about this asset. These are educational prompts, not trading signals or recommendations.
- Business activities described in the company reference
- Original company disclosures and industry classification